KLF4 and breast cancer: For example, miR‐7 inhibits the ability of breast cancer stem‐like cells to spread into the brain through modulating KLF4 [14]; miR‐7 directly inhibits SETDB1 and reverses the epithelial–mesenchymal transition of breast cancer stem‐like cells.